A study by scientists at Sanford Burnham Prebys Medical Discovery Institute suggests that a protein called membralin is critical for keeping Alzheimer’s disease pathology in check and could provide a new path toward future treatments for Alzheimer’s disease. Read more.
© 2019 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder